Please Wait...

Trident IRT

Bioclinica's Trident is the industry's only IRT system that provides advanced visibility to working study prototypes within just a few days - letting you build, implement, test and deploy new protocols in as little as two weeks, with or without customization. And Trident's integration with Bioclinica's Optimizer supply management software lets you identify and adjust enrollment rates and supply needs based on trial actuals, so you get to database lock faster, with significantly lower cost and effort, and with higher-quality data.

Rapid Start Up of Complex Studies


DOWNLOAD INFOGRAPHIC

Set up, test, and deploy study protocols within weeks instead of months with Trident — a parameter-driven Interactive Response Technology (IRT) solution. Because the programming is already done, little or no system development effort is required. In fact, Trident reduces the average set up time 50 to 75 percent compared to IRT systems built from the ground up for each new study.

Rapid configuration combined with robust functionality make Trident the IRT of choice for fast launch of complex clinical studies. Built-in alerts and notifications provide proactive tools that help bridge the gap between sites and supply chain management. Adaptive study design, temperature controlled supply management, and drug accountability are standard features. Additionally, a unique set of high-performance capabilities make Trident a best-in-class IRT for the most demanding studies.

Trident IRT provides the ideal solution for the following:

Subject Randomization

Randomizing study subjects into treatment arms for clinical trials can be a difficult and complex undertaking. Study subject bias can be introduced during randomization. Increasingly complex study designs and treatment scenarios complicate the process. Trident simplifies randomization and minimizes study subject allocation bias using proven statistical methods.

Additionally, Trident IRT:

  • Re-randomizes subjects into another treatment arm for another study phase.
  • Randomizes another study subject into a treatment group to replace dropped participants without disrupting study balance.
  • Supports extension studies, rolling over qualified subjects from one study to another.

Drug Tracking, Dispensing and Reconciliation

Trident is tailored to visit-specific strata, making it easy to manage complex dosing scenarios. Because it is configurable for predictive re-supply based on actual demand, Trident eliminates drug supply over-stocks and stock-outs. Additional value-added features include:

  • A controlled substance inventory management tool provides tracking and monitoring to the pill level. Set customizable site inventory limit controls, shipment restrictions, and threshold alerts. Track medication status along the entire supply chain and know whether it was taken, disposed, lost, destroyed, or returned.
  • Drug pooling functionality minimizes drug waste and eliminates unnecessary labeling costs.
  • Combine Trident and Optimizer, Bioclinica's advanced supplies simulation and forecasting tool, for a global supply management solution. Manage clinical supplies based on actual usage and forecasting consumption to significantly minimize waste and reduce costs.

User Requirement Specifications

While the Trident User Requirements Specification is short and simplified, it is fully comprehensive and designed to enable Bioclinica to define the study and match all of your parameters.

This creates a smooth process that helps eliminate errors, misunderstandings, and unwelcome surprises. Built precisely to your specifications, Trident is an easy to validate IRT. Since voice and web components are integrated, there is only one system setup.

Intuitive User Experience

Trident is the intuitive, easy to use IRT designed for the way users actually work. Trident maximizes user productivity and minimizes frustration. Clean screen layout and straightforward navigation guide users to complete tasks in logical progression. Users appreciate the ability to correct data entry errors and print reports when needed. Sites find it especially useful to access reports on their dashboard. System performance is fast and flexible and multiple languages are supported. Since it is so easy to use, training is brief — less than an hour.

Contact us to take Trident IRT for a test drive and see why Bioclinica's global customers use it for the most complicated study scenarios.

Trident IRT Resources

White Papers

Feasibility of shipping clinical trial drugs directly to patients' homes

Depot-to-patient dispensing is a novel approach to the distribution of study drug that can respond to the subject's clinical needs regardless of whether the visit is conducted at the clinic or via telephone.

Agile IRT: Improving Quality and Efficiency in the Study Build Process

Clinical trials are frequently required to run large numbers of patients through blinding (or masking) processes.

Blogs

The Value of Protocol Review

One of our strategic customers recently invited me to review a draft protocol synopsis for a pivotal Phase III registration study. As the provider of the randomization and trial supply management (RTSM) solution  for the study, I relished the opportunity.

The clinical randomization and supply chain management systems we now dub “IRT” were initially built as fully customized IT projects, individualized and implemented separately for each study.

Join us for our upcoming webinar on September 13th during which Bioclinica experts Senior Director of RTSM Operations and Commercial Solutions, and Robin Barber, Manager of R

ADDITIONAL RESOURCES

Bioclinica Agile RTSM

Download Overview Sheet

Trident IRT

Download data sheet

Trident IRT Reporting Capabilities

Download Data Sheet

Agile IRT: Improving Quality and Efficiency in the Study Build Process

Download White Paper

Feasibility of shipping clinical trial drugs
directly to patients' homes

Download Case Study

THE AGILE APPROACH TO BIOCLINICA'S TRIDENT IRT.

Download Infographic

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

https://t.co/UZQTot9ovJ
bioclinica (18 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (18 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (18 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: https://t.co/14eepSOR7b #ITTX17
bioclinica (18 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence, https://t.co/XaEctKIFRx
bioclinica (18 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam https://t.co/8WxeftiCPv
bioclinica (18 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices